(19)
(11) EP 4 157 463 A1

(12)

(43) Date of publication:
05.04.2023 Bulletin 2023/14

(21) Application number: 21737121.0

(22) Date of filing: 01.06.2021
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
C07D 207/12(2006.01)
C07D 211/04(2006.01)
C07D 217/06(2006.01)
C07D 403/12(2006.01)
A61K 31/40(2006.01)
A61K 31/4462(2006.01)
A61K 31/4025(2006.01)
C07D 207/06(2006.01)
C07D 209/44(2006.01)
C07D 211/42(2006.01)
C07D 401/12(2006.01)
C07D 471/04(2006.01)
A61K 31/4045(2006.01)
A61K 31/4035(2006.01)
A61K 31/407(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 207/06; C07D 207/12; C07D 211/04; C07D 211/42; C07D 209/44; C07D 471/04; C07D 403/12; C07D 401/12; C07D 217/06; A61P 35/00
(86) International application number:
PCT/GB2021/051349
(87) International publication number:
WO 2021/245405 (09.12.2021 Gazette 2021/49)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.06.2020 GB 202008201

(71) Applicant: Neophore Limited
Altrincham Cheshire WA14 2DT (GB)

(72) Inventors:
  • BLAGG, Julian
    London Greater London N1C 4AG (GB)
  • ROFFEY, Jon
    London Greater London N1C 4AG (GB)
  • DRYSDALE, Martin
    London Greater London N1C 4AG (GB)
  • WINSHIP, Paul
    Walden Essex CB10 1X (GB)
  • CLARK, David
    Walden Essex CB10 1X (GB)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT